Return On Equity of BriaCell Therapeutics Corp. from 30 Apr 2023 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BriaCell Therapeutics Corp. quarterly and annual Return On Equity in % history and change rate from 30 Apr 2023 to 31 Oct 2025.
  • BriaCell Therapeutics Corp. Return On Equity for the quarter ending 31 Oct 2025 was -274%, a 156% decline year-over-year.
  • BriaCell Therapeutics Corp. annual Return On Equity for 2025 was -291%, a 323% decline from 2024.
  • BriaCell Therapeutics Corp. annual Return On Equity for 2024 was 130%, a 99% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -274% -765% -156% 01 Aug 2025 31 Oct 2025
Q2 2025 -291% -421% -323% 01 May 2025 31 Jul 2025
Q1 2025 -480% -632% -416% 01 Feb 2025 30 Apr 2025
Q4 2024 2344% +2018% +619% 01 Nov 2024 31 Jan 2025
Q3 2024 491% -135% -22% 01 Aug 2024 31 Oct 2024
Q2 2024 130% -13058% -99% 01 May 2024 31 Jul 2024
Q1 2024 152% +695% 01 Feb 2024 30 Apr 2024
Q4 2023 326% 01 Nov 2023 31 Jan 2024
Q3 2023 626% 01 Aug 2023 31 Oct 2023
Q2 2023 13188% 01 May 2023 31 Jul 2023
Q1 2023 -544% 01 Feb 2023 30 Apr 2023

BriaCell Therapeutics Corp. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -291% -421% -323% 01 Aug 2024 31 Jul 2025
2024 130% -13058% -99% 01 Aug 2023 31 Jul 2024
2023 13188% 01 Aug 2022 31 Jul 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.